Difficulty: Medium
Average Score: 80%
Practice
An Investigational New Drug is filed with the U.S. Food and Drug Administration:
Correct answer
D
Rationale
Choice D is correct because an IND filing is required before human testing (phase I trials) to ensure safety data from preclinical studies supports proceeding, per FDA rules. Choice A is incorrect as phase III completion is too late├óÔé¼ÔÇØIND precedes all human trials. Choice B is wrong because discovery alone doesn't trigger filing; preclinical data is needed. Choice C is incorrect since animal testing occurs before the IND, not after.